Skip to main navigation Skip to search Skip to main content

A Multi-Center, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Two Lenalidomide Dose Regimens in Subjects with Relapsed or Refractory B-CELL Chronic Lymphocytic Leukemia

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date09/22/06 → 09/30/09

Funding

  • Celgene Corporation: $6,000.00